“Rising costs across the board, combined with funding that was decreasing in real terms, have left pharmacy owners making impossible choices – for larger companies this has meant closures of pharmacy branches, and for smaller independent pharmacies we have seen enormous personal tolls, and increasing numbers of business insolvencies,” she said.
